Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-21-017002

Options or other derivatives

  • Executive Vice President acquired 318,534 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Todisco Joseph Executive Vice President 2021-03-01 Grant or award · Restricted Stock Units +106,178 106,178 D
Todisco Joseph Executive Vice President 2021-03-01 Grant or award · Performance-Based Restricted Stock Units +212,356 212,356 D
Loading xslF345X03/doc4.xml…